U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Research Topics
  
  Home< Back ToResearch TopicsCOPD Research
  COPD Research
Language switcherEnglishEspañol
IN THIS ARTICLE
        View More
        View Less
As part of its broader commitment to research on lung diseases, the NHLBI leads and supports research and programs on chronic obstructive pulmonary disease (COPD) in the United States and around the world. Research supported by the NHLBI has shown that certain treatments and lifestyle changes, such as quitting smoking, can help people with COPD stay more active and slow the progression of. Current studies look at the potential benefits of treating COPD in its earliest stages.
More on COPD
      Icon of document with medical cross symbol
      Patient information
              Icon of a microscope
      Find a clinical trial
  NHLBI research that really made a difference

            **COPD National Action Plan:** The NHLBI, with input from federal and nonfederal partners, developed the COPD National Action Plan to guide nationwide efforts to reduce the burden of COPD. The goals of the plan include improved diagnosis, prevention, and treatment; improved surveillance and analysis of COPD public health data; and enhanced research to better understand and control the disease.**Awareness and care guidelines:** In 1998, the NHLBI helped launch the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to promote worldwide COPD awareness. In 2001, the first GOLD workshop report provided the initial guidelines for the diagnosis and management of COPD. GOLD, which now operates independently from the NHLBI, currently publishes annual reports to update these guidelines in line with new research findings. GOLD has also published educational materials for healthcare providers and for people who have COPD.**Lung volume reduction surgery:** The National Emphysema Treatment Trial (NETT) was the first multi-center trial to study whether a surgical procedure called lung volume reduction surgery (LVRS) was a safe and effective treatment for patients who have COPD with emphysema as its main component. Emphysema is a condition caused by damage to the walls between the air sacs in the lungs. The trial results showed that LVRS can help improve breathing and quality of life in people who have emphysema in the upper part of their lungs and who cannot get enough oxygen during physical activity. These results have helped doctors recommend the right treatment options for people who have COPD.

          
Current research funded by the NHLBI

            Our Division of Lung Diseases and its Airway Biology and Disease Branch oversee much of the research on COPD we fund.Research funding

Find funding opportunities and program contacts for COPD research.Current research on genetics and COPD**Biomarkers and COPD:** NHLBI-funded researchers are looking at lung tissue samples to identify proteins that could be biomarkers, indicators that COPD may develop. Through this genetic analysis, the researchers hope to gain insight into the biological underpinnings of COPD, which may help in designing future clinical trials and improving treatment.**Risk factors for COPD:** The SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS II) uses information from lung tests, biological specimens, imaging, and genetic testing to help us understand what raises a person’s risk of COPD and how COPD develops. It also identifies new biomarkers to predict COPD symptoms and progression. SPIROMICS participates in NHLBI’s Trans-Omics for Precision Medicine (TOPMed) program, which makes the study’s data available to other program investigators.**Genetic therapies:** NHLBI-funded researchers are developing new approaches to genetic therapies that treat alpha-1 antitrypsin deficiency (AAT). AAT is a genetic condition that can raise the risk of COPD.Find more NHLBI-funded studies on genetics and COPD at NIH RePORTER.Current research on the early stages and development of COPDEarly detection: The SPIROMICS Study of Early COPD Progression (SOURCE) looks for the earliest signs of COPD. It uses questionnaires, breathing tests, imaging, and biospecimens to test different hypotheses about how people with a history of smoking develop lung obstruction and why some people develop COPD and others do not.Predictors of lung health: The Lung Health Cohort (LHC) is a population-based cohort study of members of the millennial generation. Its goal is to characterize behavioral, environmental, and biological predictors of lung health in early adulthood.Smoking and COPD: The MESA COPD Study from Columbia University looks at how changes to the blood vessels of smokers’ lungs may contribute to the loss of lung function in COPD. The MESA COPD Study is part of the NHLBI-sponsored Multi-Ethnic Study of Atherosclerosis medical research study.Current research on health disparitiesCOPD in rural populations: In 2019, the NHLBI established the Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) to address COPD and other diseases that may affect rural populations more than others. Researchers are examining how lifestyle and genetic, environmental, and socioeconomic factors affect a person’s risk of serious heart and lung conditions. The study is recruiting about 4,000 participants in rural counties in Alabama, Kentucky, Louisiana, and Mississippi. Researchers use a mobile van with an examination unit and a computed tomography (CT) scanner to reach participants.African Americans and COPD: NHLBI-funded researchers are conducting an in-depth study of COPD in African Americans. This study uses data and samples collected as part of other NHLBI-funded long-term studies on COPD to identify new markers that determine a person’s risk of COPD and to diagnose early COPD. The study’s results will help improve the prevention, diagnosis, and treatment of this disease.Find more NHLBI-funded studies on COPD and health disparities at NIH RePORTER.Current research on diagnosis and treatmentScreening: The COPD Assessment in Primary Care to Identify Undiagnosed Respiratory Disease & Exacerbation Risk (CAPTURE) Study validates a simple tool for COPD screening in primary care settings that will help to identify people with undiagnosed COPD. Researchers are confirming that a quick breathing test and a simple questionnaire can help reach patients who are likely to benefit from treatment for COPD.NHLBI News
      
                    
                    

                                            
            Learn more about the CAPTURE Study: Screening tool aims to help doctors diagnose more people with COPD.
New treatments: The Pulmonary Trials Cooperative brought together patients, researchers, and healthcare professionals from more than 50 institutions with a common goal of developing new treatments for lung diseases. This program included three clinical trials on COPD.Find more NHLBI-funded studies on COPD treatment at NIH RePORTER.

          
COPD research labs at the NHLBI

            Research from the NHLBI Laboratory of Asthma and Lung Inflammation on the NIH campus is focused on developing new treatments for COPD.Read more about these projects and ongoing clinical trials.

          
Related COPD programs

            *Learn More Breathe Better®* is a national health education program for COPD, asthma, and other lung and respiratory diseases. The program raises awareness about COPD and supports the promotion, implementation, and adoption of evidence-based care. *Learn More Breathe Better*® has tools and handouts for patients, including tips for living better with COPD. Read about how NHLBI’s *Learn More Breathe Better*® program helps local communities ease the burden of COPD.The Molecular Atlas of Lung Development Program (LungMAP) maps the tissues, cells, genes, and molecules that make up the developing lung. The program advances lung research, in part through its web-based data resource called BREATH, which allows users to access LungMAP data and findings. Nearly 100 research papers have been produced using LungMAP data, and the program’s maps have helped scientists understand the complex processes that control the growth, structure, and function of the lungs.
  Explore more NHLBI research on COPD

            The sections above provide you with the highlights of NHLBI-supported research on COPD. You can explore the full list of NHLBI-funded studies on the NIH RePORTER.
      
            To find more studies:

Type your search words into the Quick Search box and press enter.
	Check Active Projects if you want current research.
	Select the Agencies arrow, then the NIH arrow, then check NHLBI.If you want to sort the projects by budget size — from the biggest to the smallest — click on the FY Total Cost by IC column heading.
  Last updated on October 25, 2023 Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs